The effect of glutamine therapy on outcomes in critically ill patients: A meta-analysis of randomized controlled trials

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Chen, Qi Hong ^a   Yang, Yi ^a   He, Hong Li ^a   Xie, Jian Feng ^a   Cai, Shi Xia ^a   Liu, Ai Ran ^a   Wang, Hua Ling ^b   Qiu, Hai Bo ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FEBUXOSTAT; PLACEBO; URIC ACID; GLUTAMINE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DETERIORATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; URIC ACID BLOOD LEVEL; YOUNG ADULT; CRITICAL ILLNESS; CROSS INFECTION; DIET SUPPLEMENTATION; LENGTH OF STAY; META ANALYSIS; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; TRENDS;

CRITICAL ILLNESS; CROSS INFECTION; DIETARY SUPPLEMENTS; GLUTAMINE; HUMANS; LENGTH OF STAY; MORTALITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84892161374     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13185     Document Type: Article

References (34)

1. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid?. Nutr Rev 1990, 48:297-309.
2. Long CL, Borghesi L, Stahl R, Clark JA, Geiger JW, DiRienzo DB, Weis JK, Laws HL, Blakemore WS. Impact of enteral feeding of a glutamine-supplemented formula on the hypoaminoacidemic response in trauma patients. J Trauma 1996, 40:97-102. 10.1097/00005373-199601000-00018, 8577007.
3. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns?. Lancet 1990, 336:523-525. 10.1016/0140-6736(90)92083-T, 1975037.
4. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90. 10.1007/s001340000703, 11280678.
5. Khan J, Iiboshi Y, Cui L, Wasa M, Sando K, Takagi Y, Okada A. Alanyl-glutamine-supplemented parenteral nutrition increases luminal mucus gel and decreases permeability in the rat small intestine. JPEN J Parenter Enteral Nutr 1999, 23:24-31. 10.1177/014860719902300124, 9888414.
6. Gianotti L, Alexander JW, Gennari R, Pyles T, Babcock GF. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr 1995, 19:69-74. 10.1177/014860719501900169, 7658604.
7. Inoue Y, Grant JP, Snyder PJ. Effect of glutamine-supplemented intravenous nutrition on survival after Escherichia coli-induced peritonitis. JPEN J Parenter Enteral Nutr 1993, 17:41-46. 10.1177/014860719301700141, 8437323.
8. Ardawi MS. Effect of glutamine-enriched total parenteral nutrition on septic rats. Clin Sci (Lond) 1991, 81:215-222.
9. Saito H, Furukawa S, Matsuda T. Glutamine as an immunoenhancing nutrient. JPEN J Parenter Enteral Nutr 1999, 23:S59-S61. 10.1177/014860719902300515, 10483897.
10. Buchman AL. Glutamine: is it a conditionally required nutrient for the human gastrointestinal system?. J Am Coll Nutr 1996, 15:199-205. 10.1080/07315724.1996.10718590, 8935435.
11. Estívariz CF, Griffith DP, Luo M, Szeszycki EE, Bazargan N, Dave N, Daignault NM, Bergman GF, McNally T, Battey CH, Furr CE, Hao L, Ramsay JG, Accardi CR, Cotsonis GA, Jones DP, Galloway JR, Ziegler TR. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN J Parenter Enteral Nutr 2008, 32:389-402. 10.1177/0148607108317880, 3062504, 18596310.
12. Pérez-Bárcena J, Regueiro V, Marsé P. Glutamine as a modulator of the immune system of critical care patients: effect on Toll-like receptor expression. A preliminary study. Nutrition 2008, 24:522-527. 10.1016/j.nut.2008.01.056, 18367379.
13. Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López-Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM, González-Ojeda A. L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr 2008, 32:403-411. 10.1177/0148607108319797, 18596311.
14. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497. 10.1056/NEJMoa1212722, 23594003, Canadian Critical Care Trials Group.
15. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542. 10.1136/bmj.d1542, 21415104, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group.
16. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13. 10.1186/1471-2288-5-13, 1097734, 15840177.
17. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2013, 32:213-223. 10.1016/j.clnu.2012.11.003, 23196117.
18. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
19. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999, 15:108-115. 10.1016/S0899-9007(98)00172-5, 9990574.
20. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC, López J, Acosta JA. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition 2002, 18:716-721. 10.1016/S0899-9007(02)00847-X, 12297203.
21. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, Kahana M. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001, 29:2075-2080. 10.1097/00003246-200111000-00006, 11700398.
22. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G, A.S.P.E.N. Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009, 33:277-316. 10.1177/0148607109335234, 19398613, A.S.P.E.N. Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine.
23. Schulman AS, Willcutts KF, Claridge JA, Evans HL, Radigan AE, O'Donnell KB, Camden JR, Chong TW, McElearney ST, Smith RL, Gazoni LM, Farinholt HM, Heuser CC, Lowson SM, Schirmer BD, Young JS, Sawyer RG. Does the addition of glutamine to enteral feeds affect patient mortality?. Crit Care Med 2005, 33:2501-2506. 10.1097/01.CCM.0000185643.02676.D3, 16276173.
24. Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G, Barrera-Zepeda LM. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 2004, 23:13-21. 10.1016/S0261-5614(03)00055-4, 14757388.
25. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008, 34:1980-1990. 10.1007/s00134-008-1213-6, 18626628.
26. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002, 30:2032-2037. 10.1097/00003246-200209000-00013, 12352037.
27. Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 2003, 29:1710-1716. 10.1007/s00134-003-1937-2, 12923621.
28. Falcão de Arruda IS, de Aguilar-Nascimento JE. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci (Lond) 2004, 106:287-292. 10.1042/CS20030251, 14558885.
29. Déchelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coëffier M, Hecketsweiler B, Merle V, Mazerolles M, Samba D, Guillou YM, Petit J, Mansoor O, Colas G, Cohendy R, Barnoud D, Czernichow P, Bleichner G. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006, 34:598-604. 10.1097/01.CCM.0000201004.30750.D1, 16505644.
30. Pérez-Bárcena J, Crespí C, Regueiro V, Marsé P, Raurich JM, Ibáñez J, García de Lorenzo-Mateos A, Bengoechea JA. Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit. Crit Care 2010, 14:R233. 10.1186/cc9388, 3219991, 21184675.
31. Wernerman J, Kirketeig T, Andersson B, Berthelson H, Ersson A, Friberg H, Guttormsen AB, Hendrikx S, Pettilä V, Rossi P, Sjöberg F, Winsö O, Scandinavian Critical Care Trials Group Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 2011, 55:812-818. 10.1111/j.1399-6576.2011.02453.x, 21658010, Scandinavian Critical Care Trials Group.
32. Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P, Metabolism, Nutrition Working Group, SEMICYUC, Spain The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011, 39:1263-1268. 10.1097/CCM.0b013e31820eb774, 21336131, Metabolism, Nutrition Working Group, SEMICYUC, Spain.
33. Heyland DK, Dhaliwal R. Role of glutamine supplementation in critical illness given the results of the REDOXS study. JPEN J Parenter Enteral Nutr 2013, 37:442-443. 10.1177/0148607113488421, 23639898.
34. Rodas PC, Rooyackers O, Hebert C, Norberg T, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597. 10.1042/CS20110520, 3294430, 22248298.